Sulfasalazine Tablet (500mg) SULFASALAZ 500 15'S is a medication that belongs to the class of disease-modifying anti-rheumatic drugs (DMARDs).SULFASALAZ 500 15'S is commonly used in the treatment of inflammatory bowel diseases (such as ulcerative colitis and Crohn's disease) and certain types of arthritis. SULFASALAZ 500 15'S is used to treat conditions like ulcerative colitis and Crohn's disease, which are characterized by inflammation in the gastrointestinal tract. SULFASALAZ 500 15'S may also be prescribed for certain types of arthritis, particularly rheumatoid arthritis. Mechanism of Action: SULFASALAZ 500 15'S is a prodrug that is broken down in the body to release two active components: sulfapyridine and 5-aminosalicylic acid (5-ASA). These components have anti-inflammatory effects that help reduce inflammation in the intestines and joints. SULFASALAZ 500 15'S is typically taken orally, usually with food to minimize gastrointestinal side effects. The tablets should be swallowed whole, not crushed or chewed. Monitoring: Regular monitoring, including blood tests, may be required to assess the response to treatment and to check for potential side effects, such as changes in blood cell counts or liver function. Side Effects: Common side effects may include nausea, vomiting, loss of appetite, and headache. Some individuals may also experience allergic reactions.SULFASALAZ 500 15'S important to report any unusual or severe side effects to a healthcare provider. Precautions and Contraindications: SULFASALAZ 500 15'S may not be suitable for individuals with certain medical conditions, such as a history of allergies to sulfonamide drugs or intestinal or urinary blockage. SULFASALAZ 500 15'S important to inform the healthcare provider about any existing medical conditions and all medications, including over-the-counter drugs and supplements. The duration of treatment with sulfasalazine depends on the specific condition being treated. SULFASALAZ 500 15'S is often used as a long-term therapy for chronic inflammatory conditions. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/sulfasalaz-500-15-s-133973